These effects, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the principle of focusing on ACKR3 as a novel approach to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related Diseases.Gene expression Evaluation exposed that ACKR3